Alzheimer’s and tauopathy research progresses with recombinant proteins sourced from rPeptide including tau-441 for phosphorylation studies, aggregation mechanisms, and neurodegenerative pathology exploration worldwide by dedicated scientists.
Wednesday, November 4, 2026